HK1184391A1 - Oral pharmaceutical tablet for controlled release of mesalazine and process for obtaining it - Google Patents

Oral pharmaceutical tablet for controlled release of mesalazine and process for obtaining it

Info

Publication number
HK1184391A1
HK1184391A1 HK13111956.4A HK13111956A HK1184391A1 HK 1184391 A1 HK1184391 A1 HK 1184391A1 HK 13111956 A HK13111956 A HK 13111956A HK 1184391 A1 HK1184391 A1 HK 1184391A1
Authority
HK
Hong Kong
Prior art keywords
mesalazine
obtaining
controlled release
oral pharmaceutical
pharmaceutical tablet
Prior art date
Application number
HK13111956.4A
Other languages
English (en)
Inventor
Blas David Loeches
Fernández-Molina Roberto Varas
Pérez Mercedes Martínez
Original Assignee
Liconsa Laboratorios Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liconsa Laboratorios Sa filed Critical Liconsa Laboratorios Sa
Publication of HK1184391A1 publication Critical patent/HK1184391A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK13111956.4A 2010-12-27 2013-10-24 Oral pharmaceutical tablet for controlled release of mesalazine and process for obtaining it HK1184391A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10382355A EP2468264A1 (en) 2010-12-27 2010-12-27 Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it
PCT/EP2011/073983 WO2012089677A1 (en) 2010-12-27 2011-12-23 Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it

Publications (1)

Publication Number Publication Date
HK1184391A1 true HK1184391A1 (en) 2014-01-24

Family

ID=43901549

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13111956.4A HK1184391A1 (en) 2010-12-27 2013-10-24 Oral pharmaceutical tablet for controlled release of mesalazine and process for obtaining it

Country Status (17)

Country Link
US (1) US20130273156A1 (da)
EP (2) EP2468264A1 (da)
JP (1) JP2014501267A (da)
CN (1) CN103269691A (da)
BR (1) BR112013016461A2 (da)
CA (1) CA2822754A1 (da)
DK (1) DK2621477T3 (da)
ES (1) ES2463040T3 (da)
HK (1) HK1184391A1 (da)
HR (1) HRP20140479T1 (da)
PL (1) PL2621477T3 (da)
PT (1) PT2621477E (da)
RS (1) RS53363B (da)
RU (1) RU2013125148A (da)
SA (1) SA111330110B1 (da)
SI (1) SI2621477T1 (da)
WO (1) WO2012089677A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105025888B (zh) * 2013-02-22 2018-10-12 志瑞亚新药工业株式会社 肠溶片
CN103211780B (zh) * 2013-04-17 2015-10-14 沈阳药科大学 美沙拉嗪口服结肠定位粘附微丸
PT3227273T (pt) 2014-12-02 2022-04-06 Minerva Neurosciences Inc Composições que compreendem 2-((1-(2(4-fluorofenil)-2-oxoetil)piperidin-4-il)metil)isoindolin-1-ona para tratamento de esquizofrenia
EP3162362A1 (de) 2015-10-30 2017-05-03 Dr. Falk Pharma Gmbh Optimierte mesalazinhaltige hochdosistablette
ITUB20160203A1 (it) * 2016-01-19 2017-07-19 Valpharma Int Spa Formulazioni in compresse a rilascio modificato contenenti Mesalazina ad alto dosaggio, processo per la loro preparazione e loro uso.
ITUA20162293A1 (it) * 2016-04-05 2017-10-05 Sofar Spa Processo per formulazioni solide di mesalazina
EP3445340A1 (en) * 2016-04-19 2019-02-27 Ferring B.V. Oral pharmaceutical compositions of mesalazine
WO2017184563A1 (en) 2016-04-19 2017-10-26 Ferring B.V. Oral pharmaceutical compositions of nicotinamide
CN105902500B (zh) * 2016-04-27 2019-11-29 上海理工大学 一种美沙拉嗪肠溶定位控释制剂及其制备方法
US11464744B2 (en) * 2017-06-21 2022-10-11 Minerva Neurosciences, Inc. Gastro-resistant controlled release oral dosage forms
MX2021002017A (es) 2018-08-21 2021-04-28 Minerva Neurosciences Inc Uso de roluperidona para tratar sintomas y trastornos negativos, aumentar la neuroplasticidad y promover la neuroproteccion.
IT201800011120A1 (it) * 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide per la somministrazione di mesalazina o suoi derivati
IT202000011050A1 (it) * 2020-05-14 2021-11-14 Mogon Pharmaceuticals Sagl Composizioni orali solide comprendenti matrici monolitiche composite per la somministrazione cronotropica nel tratto gastroenterico di ingredienti attivi

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692484B1 (fr) * 1992-06-22 1995-06-30 Gouchet Franck Nouvelle forme galenique de 4-asa a liberation controlee.
ITMI991316A1 (it) 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
IT1318625B1 (it) * 2000-07-14 2003-08-27 Roberto Valducci Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.
US20070059368A1 (en) * 2005-05-31 2007-03-15 Cherukuri S R Modified release formulations of anti-irritability drugs
AU2003225102A1 (en) * 2002-04-23 2003-11-10 Bristol-Myers Squibb Company Modified-release vasopeptidase inhibitor formulation, combinations and method
US7825106B2 (en) * 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
SG147450A1 (en) * 2003-10-29 2008-11-28 Wyeth Corp Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
AU2005256653B2 (en) * 2004-06-28 2010-10-14 Solvay Pharmaceuticals B.V. Oral sustained release formulation of tedisamil with gastric retention properties
JP2008506668A (ja) * 2004-07-15 2008-03-06 ソルベイ・フアーマシユーチカルズ・ベー・ブイ ３−アミノ−８−（１−ピペラジニル）−２ｈ−１−ベンゾピラン−２−オンの長時間放出型調製物
JP5041774B2 (ja) * 2006-09-22 2012-10-03 日本ケミファ株式会社 メサラジンを有効成分として含有する徐放性錠剤

Also Published As

Publication number Publication date
WO2012089677A1 (en) 2012-07-05
ES2463040T3 (es) 2014-05-27
EP2621477A1 (en) 2013-08-07
HRP20140479T1 (hr) 2014-07-04
CA2822754A1 (en) 2012-07-05
RU2013125148A (ru) 2015-02-10
SA111330110B1 (ar) 2014-08-11
JP2014501267A (ja) 2014-01-20
CN103269691A (zh) 2013-08-28
EP2468264A1 (en) 2012-06-27
DK2621477T3 (da) 2014-06-16
US20130273156A1 (en) 2013-10-17
RS53363B (en) 2014-10-31
PT2621477E (pt) 2014-05-30
PL2621477T3 (pl) 2014-08-29
BR112013016461A2 (pt) 2016-09-27
EP2621477B1 (en) 2014-03-19
SI2621477T1 (sl) 2014-07-31

Similar Documents

Publication Publication Date Title
HK1184391A1 (en) Oral pharmaceutical tablet for controlled release of mesalazine and process for obtaining it
HK1255336A1 (zh) 藥物製劑及其製備方法
IL220037A0 (en) Compressible-coated pharmaceutical composiitons and tablets and methods of manufacture
EP2635233A4 (en) SYSTEM AND METHOD FOR DUPLICATING A TOOTH SET
EP2595597A4 (en) DEVICE AND METHOD FOR ENCAPSULATING CAPSULES OR OTHER SOLID GALENIC FORMS IN CAPSULES
EP2448406A4 (en) ORAL PHARMACEUTICAL COMPOSITIONS OF 3-HYDROXY-N-METHYLMORPHINAN WITH DELAYED RELEASE AND METHOD OF USE THEREOF
HK1178422A1 (en) Medicine dispenser and method of discharging medicine
IL223099A0 (en) Tracking and delivery confirmation of pharmaceutical products
IL214624A0 (en) Controlled release pharmaceutical formulations of nitazoxanide
EP2635232A4 (en) SYSTEM AND METHOD FOR OPTIMIZING DENTAL PROSTHESES
IL219276A0 (en) Gastroretentive dosage forms of poorly soluble drugs
EP2564845A4 (en) MEDICINE FOR TREATING HYPERPLASIC AND INFLAMMATORY DISORDERS IN HUMANS BASED ON DIINDOLYLMETHANE
ZA201402864B (en) A gastroretentive dosage system and process of preparation thereof
HK1183228A1 (zh) 口服藥物治療方法和組合物
IL225606A0 (en) A method for preparing an inactive supplement suitable for pharmaceutical use
PT2665471T (pt) Formas de dosagem farmacêutica orais de libertação controlada que compreendem mgbg
HUE037197T2 (hu) Javított kioldódású meszalazin tabletta
SI2533766T1 (sl) Farmacevtske minitablete za zakasnjeno sproščanje flekainid acetata
ZA201304731B (en) Pharmaceutical composites of poorly water soluble drugs and polymers
RS55359B1 (sr) Kapsula i uređaj za korišćenje navedene kapsule
HUP1000357A2 (en) Pharmaceutical and food products suitable for activating of glucose-transporters
EP2760435A4 (en) AUTHENTICABLE COATINGS FOR PHARMACEUTICAL TABLETS AND INGREDIENTS
SI2654723T1 (sl) Trdne farmacevtske dozirna oblike, ki obsegajo tadalafil in metode za njihovo pripravo
EP2570121A4 (en) SLOW-DOWN MEDICAMENT TABLET BASED ON ANTITUMOR PLANT COMPRISING ELEMEN
BR112013014963A2 (pt) comprimido farmacêutico de liberação controlada para administração oral

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171223